Pre-emptive pharmacogenetic (PGx) testing using a multiple gene panel to guide treatment and reduce adverse drug reactions
Topic Status Complete
Pre-emptive pharmacogenetic (PGx) testing using a multiple gene panel to guide treatment decisions
Summary
Health Technology Wales researchers searched for evidence on the clinical and cost effectiveness of pre-emptive testing using a PGx panel to guide treatment and reduce adverse drug reactions.
The HTW Assessment Group decided not to progress this topic further due to the lack of evidence of effectiveness at present.
Topic Exploration Report
TER465 09.2023